These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Nonmyeloablative conditioning allows for more rapid T-cell repertoire reconstitution following allogeneic matched unrelated bone marrow transplantation compared to myeloablative approaches. Friedman TM; Varadi G; Hopely DD; Filicko J; Wagner J; Ferber A; Martinez J; Brunner J; Grosso D; McGuire L; Korngold R; Flomenberg N Biol Blood Marrow Transplant; 2001; 7(12):656-64. PubMed ID: 11787528 [TBL] [Abstract][Full Text] [Related]
3. Overview of bone marrow and stem cell transplantation. Johns A J Intraven Nurs; 1998; 21(6):356-60. PubMed ID: 10392101 [TBL] [Abstract][Full Text] [Related]
4. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Petersen SL Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527 [TBL] [Abstract][Full Text] [Related]
5. A comparison of T-, B- and NK-cell reconstitution following conventional or nonmyeloablative conditioning and transplantation with bone marrow or peripheral blood stem cells from human leucocyte antigen identical sibling donors. Petersen SL; Ryder LP; Björk P; Madsen HO; Heilmann C; Jacobsen N; Sengeløv H; Vindeløv LL Bone Marrow Transplant; 2003 Jul; 32(1):65-72. PubMed ID: 12815480 [TBL] [Abstract][Full Text] [Related]
6. New approaches to treating malignances with stem cell transplantation. Margolis J; Borrello I; Flinn IW Semin Oncol; 2000 Oct; 27(5):524-30. PubMed ID: 11049020 [TBL] [Abstract][Full Text] [Related]
7. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation. Strober S Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036 [TBL] [Abstract][Full Text] [Related]
8. Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell-depleted hematopoietic allograft. Horwitz ME; Barrett AJ; Brown MR; Carter CS; Childs R; Gallin JI; Holland SM; Linton GF; Miller JA; Leitman SF; Read EJ; Malech HL N Engl J Med; 2001 Mar; 344(12):881-8. PubMed ID: 11259721 [TBL] [Abstract][Full Text] [Related]
9. Addition of treosulfan to a nonmyeloablative conditioning regimen results in enhanced chimerism and immunologic tolerance in an experimental allogeneic bone marrow transplant model. Ploemacher RE; Johnson KW; Rombouts EJ; Etienne K; Westerhof GR; Baumgart J; White-Scharf ME; Down JD Biol Blood Marrow Transplant; 2004 Apr; 10(4):236-45. PubMed ID: 15077222 [TBL] [Abstract][Full Text] [Related]
10. Unrelated bone marrow transplantation using a reduced intensity-conditioning regimen in leukocyte adhesion deficiency. Takahashi D; Nagatoshi Y; Saito Y; Inagaki J; Nagayama J; Shinkoda Y; Fujita K; Okamura J Bone Marrow Transplant; 2006 Apr; 37(8):807-8. PubMed ID: 16532019 [No Abstract] [Full Text] [Related]
11. Risk assessment in haematopoietic stem cell transplantation: stem cell source. Urbano-Ispizua A Best Pract Res Clin Haematol; 2007 Jun; 20(2):265-80. PubMed ID: 17448961 [TBL] [Abstract][Full Text] [Related]
12. [Nursing care of patients with allogeneic stem cell transplantation: as much everyday routine as possible]. Reidenbach C Pflege Z; 2003 Nov; 56(11):777-80. PubMed ID: 14679631 [No Abstract] [Full Text] [Related]